Explore All Access
Check if your research matches the topics covered in Clinical Lung Cancer?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Clinical Lung Cancer : Impact Factor & More
eISSN: 1938-0690pISSN: 1525-7304
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Clinical Lung Cancer is a peer-reviewed medical journal that has been published by Elsevier since 2011. It was established by the CIG Media Group in 1999.
Clinical Lung Cancer Key Metrics
CiteScore 
7.5
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.18
Time to Accept
3
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months38%
4 to 6 months49%
7 to 9 months10%
Above 9 months3%
Did you find this useful?
Topics Covered on Clinical Lung Cancer
Cancer
Lung cancer
Anaplastic lymphoma kinase
Progression-free survival
Immunotherapy
Epidermal growth factor receptor
Overall survival
Chemoradiotherapy
Lung
Receptor tyrosine kinase
Exon
Multivariate analysis
Squamous cell lung cancer
Quality of life
Objective response
Concurrent chemoradiotherapy
Computed tomography
Positron emission tomography
Lymph node
Radiation Pneumonitis
Clinical Lung Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | CIG MEDIA GROUP, LP |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Lung Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Clinical Lung Cancer
A phase II, open label, single-arm study on the efficacy of cabozantinib in patients with advanced/metastatic nonsmall cell lung cancer harboring MET exon 14 alterations who developed acquired resistance to tepotinib or capmatinib (CAPTURE trial)
- 1 Dec 2024
- Clinical Lung Cancer
PEARL: A multicenter phase 2 study of lorlatinib in patients with ALK-rearranged NSCLC and central nervous system disease
- 1 Dec 2024
- Clinical Lung Cancer
Editorial Board
- 1 Dec 2024
- Clinical Lung Cancer
Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients with Advanced Thymoma or Thymic Carcinoma
- 1 Dec 2024
- Clinical Lung Cancer
Computer Assisted Nodule Analysis and Risk Yield is Associated with Occult Lymph Node Status in Clinical Stage I-IIA Lung Adenocarcinoma Undergoing Resection
- 1 Dec 2024
- Clinical Lung Cancer
Impact of lung biomarker testing on out-of-pocket costs for metastatic non-small cell lung cancer
- 1 Nov 2024
- Clinical Lung Cancer
A phase II, open label, single-arm study on the efficacy of cabozantinib in patients with advanced/metastatic nonsmall cell lung cancer harboring MET exon 14 alterations who developed acquired resistance to tepotinib or capmatinib (CAPTURE trial)
- 1 Dec 2024
- Clinical Lung Cancer
PEARL: A multicenter phase 2 study of lorlatinib in patients with ALK-rearranged NSCLC and central nervous system disease
- 1 Dec 2024
- Clinical Lung Cancer
Editorial Board
- 1 Dec 2024
- Clinical Lung Cancer
Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients with Advanced Thymoma or Thymic Carcinoma
- 1 Dec 2024
- Clinical Lung Cancer
Computer Assisted Nodule Analysis and Risk Yield is Associated with Occult Lymph Node Status in Clinical Stage I-IIA Lung Adenocarcinoma Undergoing Resection
- 1 Dec 2024
- Clinical Lung Cancer
Impact of lung biomarker testing on out-of-pocket costs for metastatic non-small cell lung cancer
- 1 Nov 2024
- Clinical Lung Cancer
Compare Similar Journals with Clinical Lung Cancer
Select Journals to Compare with Clinical Lung Cancer
Total journals - 10
You can select up to 3 Journals at a time
Journal of Thoracic Oncology
Publisher: ELSEVIER SCIENCE INC
Lung Cancer
Publisher: ELSEVIER IRELAND LTD
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Annals of Oncology
Publisher: ELSEVIER
Thoracic Cancer
Publisher: WILEY
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
TRANSLATIONAL LUNG CANCER RESEARCH
Publisher: AME PUBLISHING COMPANY
Cancers
Publisher: MDPI
Journal of Thoracic Disease
Publisher: AME PUBLISHING COMPANY
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
Clinical Lung Cancer
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Clinical Lung Cancer
How long has Clinical Lung Cancer been actively publishing? 
Clinical Lung Cancer has been in operation since 1999 till date.
What is the publishing frequency of Clinical Lung Cancer?
Clinical Lung Cancer published with a Bi-monthly frequency.
How many articles did Clinical Lung Cancer publish last year?
In 2023, Clinical Lung Cancer publsihed 161 articles.
What is the eISSN & pISSN for Clinical Lung Cancer?
For Clinical Lung Cancer, eISSN is 1938-0690 and pISSN is 1525-7304.
What is Citescore for Clinical Lung Cancer?
Citescore for Clinical Lung Cancer is 7.5.
What is SNIP score for Clinical Lung Cancer?
SNIP score for Clinical Lung Cancer is 1.18.
What is the SJR for Clinical Lung Cancer?
SJR for Clinical Lung Cancer is Q2.
Who is the publisher of Clinical Lung Cancer?
CIG MEDIA GROUP, LP is the publisher of Clinical Lung Cancer.
